Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
SEB $1.25 billion notes offering
The investment-grade notes are due 2028
Mobileye $948 million secondary offering and $100 million share repurchase
We advised Mobileye on the registered secondary offering
Geekplus HK$2.71 billion IPO and HKEX listing
We advised Geekplus on its IPO and H share listing
Peru $1.2 billion exchange and tender offers
The offers are for seven tranches of debt
SMFG $4 billion senior and subordinated notes offerings
We advised SMFG on its SEC-registered offerings of TLAC notes
CDB Aviation Lease MTN program update and $700 million notes drawdown
The fixed-rate notes and floating-rate notes are due 2030
Mizuho Financial Group $3 billion senior notes offering
The offering included fixed-to-fixed reset rate notes and floating-rate notes
Bunge $1.9 billion senior notes exchange offer
The new Bunge notes are due 2026, 2027, 2031 and 2032
Seazen Group $300 million senior notes offering and concurrent tender offers
The high-yield notes are due 2028
Hilton $1 billion senior notes offering
The high-yield notes are due 2033